Landscape Capital Management L.L.C. bought a new position in Corteva, Inc. (NYSE:CTVA – Free Report) in the 2nd quarter, Holdings Channel.com reports. The fund bought 12,390 shares of the company’s stock, valued at approximately $1,049,000.
A number of other hedge funds and other institutional investors have also modified their holdings of CTVA. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the 3rd quarter valued at $25,000. Garton & Associates Financial Advisors LLC bought a new stake in Corteva in the fourth quarter worth $27,000. Bank of Jackson Hole Trust acquired a new position in Corteva during the fourth quarter worth $28,000. Cornerstone Financial Management LLC bought a new position in Corteva during the fourth quarter valued at about $29,000. Finally, Elevation Wealth Partners LLC raised its holdings in Corteva by 334.6% during the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after buying an additional 261 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on CTVA shares. Morgan Stanley upped their price target on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. CICC Research upped their target price on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Oppenheimer increased their price target on Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, July 23rd. Royal Bank Of Canada lifted their price target on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research report on Tuesday, July 21st. Finally, BMO Capital Markets boosted their price objective on shares of Corteva from $95.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $91.50.
Corteva Price Performance
NYSE CTVA opened at $81.84 on Monday. The stock has a 50-day simple moving average of $82.13 and a 200 day simple moving average of $80.26. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The stock has a market capitalization of $54.60 billion, a PE ratio of 54.20, a P/E/G ratio of 2.51 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.
Corteva (NYSE:CTVA – Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s revenue was down 1.2% on a year-over-year basis. During the same quarter last year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.
Corteva Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
